- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Tags
global food crisis Plant biotechnology BIO International Convention Benefits of biotech crops biotech industry One-on-One's patent climate change agriculture Partnering biofuels biotechnology Health Care Food Sustainability Biotechnology Industry biofuel Technology Transfer Industry Analysis Biofuel TechnologyAuthors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Author Archive: Abigail Hirsch
Industry Regulatory Issues to be Highlighted at 2012 BIO International Convention
In the words of BIO’s Andrew Emmett, Managing Director, Science & Regulatory Affairs, ‘2012 is shaping up to be a momentous year for FDA reform.’ From the reauthorization of the Prescription Drug User Fee Act (PDUFA V) to modernizing and expediting the approval of new drugs and biologics, implementing the new biosimilars pathways and addressing the growing global drug shortage crisis, all eyes are on the current regulatory environment and its role in supporting innovation. Read More >
2012 Orphan Disease Forum: Addressing Today’s Opportunities and Challenges
If all of the people with rare disease lived in one country, it would be the world’s third most populous country! Through dedicated companies such as the National Organization for Rare Disorders (NORD) and Centric Health Resources, the pressing issue of orphan diseases and its patients are being addressed. A rare disease is defined by any disease affecting fewer than 200,000 Americans. There are nearly 7,000 such diseases affecting over 350 million people worldwide. Furthermore, Read More >
2012 MassBioEd Innovative School of the Year – Norton High School
Massachusetts is home to the full ecosystem of life sciences—including our world class academic institutions and medical centers, a vibrant venture capital community, hundreds of biotech companies of all sizes, contract research and manufacturing organizations, and service organizations supporting the industry. It is no wonder then that eleven years ago MassBio established the Massachusetts Biotechnology Foundation to promote biotechnology education and workforce development programs. Each year, the Foundation awards the Innovative School of the Year Read More >
Abbott Laboratories: Keys for Partnering Success at the BIO International Convention
Thinking of hosting pre-qualified meetings at your BIO Exhibition booth during the 2012 BIO International Convention? Abbott Laboratories did just that at last year’s Convention and learned what it takes to succeed and secure high-quality leads. “The greatest value of partnering within our booth is that it allows us to drive traffic, activity and interest within our booth space,” said Michelle Calhoun, Abbott’s contract manufacturing sales and marketing director. During the 2011 Convention, Abbott hosted Read More >
2012 Biotech Humanitarian Award Nominations Open
BIO is now accepting nominations for the fourth annual Biotech Humanitarian Award. The Award will be given to an individual who, through their work in or support of biotechnology, is harnessing its potential to heal, fuel or feed the planet. The Humanitarian Award honors work that aims to reduce human suffering significantly or enhance the human experience in a way that has a clear and direct benefit to society. Additional consideration will be given to Read More >
